Q3 2024 Holdings
Filed 2024-11-14 | 28 holdings | $484.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $70.4M | 4,408,379 | 14.6% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $44.8M | 1,752,174 | 9.2% |
| Skye Bioscience Inc(SKYE) | COM NEW | 83086J200 | $38.8M | 9,913,168 | 8.0% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $36.4M | 2,353,304 | 7.5% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $33.7M | 1,231,619 | 7.0% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $23.9M | 478,972 | 4.9% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $22.1M | 939,298 | 4.6% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $20.5M | 1,285,000 | 4.2% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $19.6M | 646,524 | 4.0% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $19.6M | 340,000 | 4.0% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $16.9M | 497,270 | 3.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $16.8M | 736,595 | 3.5% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $15.0M | 237,560 | 3.1% |
| Pharvaris N V(PHVS) | COM | N69605108 | $14.8M | 797,600 | 3.1% |
| Erasca Inc(ERAS) | COM | 29479A108 | $14.8M | 5,405,404 | 3.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $14.2M | 282,313 | 2.9% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $12.0M | 357,733 | 2.5% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $8.7M | 476,200 | 1.8% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $8.4M | 1,050,000 | 1.7% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $6.1M | 561,854 | 1.3% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $5.5M | 1,200,647 | 1.1% |
| VOR Biopharma Inc | COM | 929033108 | $4.5M | 6,361,723 | 0.9% |
| Rallybio Corp | COM | 75120L100 | $4.2M | 3,630,724 | 0.9% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $3.8M | 572,665 | 0.8% |
| Adverum Biotechnologies Inc(AVU0) | COM NEW | 00773U207 | $3.8M | 541,666 | 0.8% |
| Mersana Therapeutics Inc | COM | 59045L106 | $2.5M | 1,305,000 | 0.5% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $1.8M | 490,000 | 0.4% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $609.8K | 56,725 | 0.1% |